With a robust background in life sciences, the fund manager has successfully completed over 50 investments in sectors such as biotechnology and medical devices. Active primarily in North America and Europe, they emphasize early-stage companies and adopt a strategic operator-first approach. Their portfolio includes several notable exits, showcasing a keen ability to identify and scale innovative solutions in healthcare. The manager's data-driven investment style ensures a thorough analysis of market trends and emerging technologies, further enhancing their reputation in the industry.